These findings further strengthen the targeting specificity of microRNA-200c and identify potential alternative EMT-regulatory pathways in cancer cells that have lost E-cadherin expression due to epigenetic modifications such as the DNA methylation. The gene discussed is CDH1; the disease is cancer.